(Q43668221)

25 November 2017

Hippocampal formation glucose metabolism and volume losses in MCI and AD. (English)

1 reference

25 November 2017

0 references

De Santi S

1

1 reference

25 November 2017

de Leon MJ

2

1 reference

25 November 2017

Rusinek H

3

1 reference

25 November 2017

Convit A

4

1 reference

25 November 2017

Tarshish CY

5

1 reference

25 November 2017

Roche A

6

1 reference

25 November 2017

Tsui WH

7

1 reference

25 November 2017

Kandil E

8

1 reference

25 November 2017

Boppana M

9

1 reference

25 November 2017

Daisley K

10

1 reference

25 November 2017

Wang GJ

11

1 reference

25 November 2017

Schlyer D

12

1 reference

25 November 2017

Fowler J

13

1 reference

25 November 2017

1 July 2001

1 reference

25 November 2017

Neurobiology of Aging

1 reference

25 November 2017

22

1 reference

25 November 2017

529-539

1 reference

25 November 2017

4

1 reference

Observations on the brains of non-demented old people

25 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900230-5

7 January 2021

Alzheimer changes in nondemented patients younger than sixty-five: possible early stages of Alzheimer's disease and senile dementia of Alzheimer type.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900230-5

7 January 2021

A quantitative histological study of early clinical and preclinical Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900230-5

7 January 2021

Neurofibrillary changes confined to the entorhinal region and an abundance of cortical amyloid in cases of presenile and senile dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900230-5

7 January 2021

Neuropathological stageing of Alzheimer-related changes

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900230-5

7 January 2021

Distribution of Alzheimer-type pathologic changes in nondemented elderly individuals matches the pattern in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900230-5

7 January 2021

Alzheimer's changes in non-demented and demented patients: a statistical approach to their relationships.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900230-5

7 January 2021

Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900230-5

7 January 2021

High frequency of apolipoprotein E epsilon4 allele in young individuals with very mild Alzheimer's disease-related neurofibrillary changes

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900230-5

7 January 2021

Tangles and plaques in nondemented aging and "preclinical" Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900230-5

7 January 2021

The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900230-5

7 January 2021

Alzheimer's disease and apolipoprotein E epsilon 4 allele in older drivers who died in automobile accidents.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900230-5

7 January 2021

Entorhinal cortex beta-amyloid load in individuals with mild cognitive impairment.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900230-5

7 January 2021

Quantitative analysis of a vulnerable subset of pyramidal neurons in Alzheimer's disease: I. Superior frontal and inferior temporal cortex.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900230-5

7 January 2021

The topographic distribution of brain atrophy in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900230-5

7 January 2021

Neuropathological indexes of Alzheimer's disease in demented and nondemented persons aged 80 years and older.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900230-5

7 January 2021

Mild cognitive impairment in the elderly: predictors of dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900230-5

7 January 2021

Mild cognitive impairment: clinical characterization and outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900230-5

7 January 2021

Early marker for Alzheimer's disease: the atrophic hippocampus.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900230-5

7 January 2021

Atrophy of medial temporal lobes on MRI in "probable" Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900230-5

7 January 2021

Specific hippocampal volume reductions in individuals at risk for Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900230-5

7 January 2021

Volume loss of the hippocampus and temporal lobe in healthy elderly persons destined to develop dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900230-5

7 January 2021

Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900230-5

7 January 2021

Presymptomatic hippocampal atrophy in Alzheimer's disease. A longitudinal MRI study.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900230-5

7 January 2021

Medial temporal lobe atrophy and memory dysfunction as predictors for dementia in subjects with mild cognitive impairment.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900230-5

7 January 2021

Atrophy of the medial occipitotemporal, inferior, and middle temporal gyri in non-demented elderly predict decline to Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900230-5

7 January 2021

Magnetic resonance imaging of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900230-5

7 January 2021

Quantification of magnetic resonance scans for hippocampal and parahippocampal atrophy in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900230-5

7 January 2021

Temporal lobe regions on magnetic resonance imaging identify patients with early Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900230-5

7 January 2021

MR‐based hippocampal volumetry in the diagnosis of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900230-5

7 January 2021

Volumes of medial temporal lobe structures in patients with Alzheimer's disease and mild cognitive impairment (and in healthy controls).

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900230-5

7 January 2021

Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900230-5

7 January 2021

MRI of the hippocampus in Alzheimer's disease: sensitivity, specificity, and analysis of the incorrectly classified subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900230-5

7 January 2021

MRI of entorhinal cortex in mild Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900230-5

7 January 2021

Usefulness of MRI measures of entorhinal cortex versus hippocampus in AD.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900230-5

7 January 2021

Regional cerebral metabolic alterations in dementia of the Alzheimer type: positron emission tomography with [18F]fluorodeoxyglucose.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900230-5

7 January 2021

Cortical abnormalities in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900230-5

7 January 2021

Positron emission tomography in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900230-5

7 January 2021

Cerebral glucose metabolic patterns in Alzheimer's disease. Effect of gender and age at dementia onset

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900230-5

7 January 2021

Longitudinal studies of regional cerebral metabolism in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900230-5

7 January 2021

Topography of cross-sectional and longitudinal glucose metabolic deficits in Alzheimer's disease. Pathophysiologic implications

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900230-5

7 January 2021

Evidence of multiple memory systems in the human brain. A [18F]FDG PET metabolic study

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900230-5

7 January 2021

Cortisol reduces hippocampal glucose metabolism in normal elderly, but not in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900230-5

7 January 2021

Altered glucose metabolism in the hippocampal head in memory impairment.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900230-5

7 January 2021

Greater metabolic rate decreases in hippocampal formation and proisocortex than in neocortex in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900230-5

7 January 2021

The neural substrates of memory systems impairment in Alzheimer's disease. A PET study of resting brain glucose utilization.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900230-5

7 January 2021

Coronal reconstruction images of glucose metabolism in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900230-5

7 January 2021

The cortical topography of temporal lobe hypometabolism in early Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900230-5

7 January 2021

Relatively preserved hippocampal glucose metabolism in mild Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900230-5

7 January 2021

Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900230-5

7 January 2021

Neuropsychological function and cerebral glucose utilization in isolated memory impairment and Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900230-5

7 January 2021

The Global Deterioration Scale for assessment of primary degenerative dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900230-5

7 January 2021

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900230-5

7 January 2021

Neuropsychological prediction of decline to dementia in nondemented elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900230-5

7 January 2021

The [14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900230-5

7 January 2021

Glucose metabolic rate kinetic model parameter determination in humans: the lumped constants and rate constants for [18F]fluorodeoxyglucose and [11C]deoxyglucose.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900230-5

7 January 2021

Interactive algorithms for the segmentation and quantitation of 3-D MRI brain scans.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900230-5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900230-5

7 January 2021

Preserved pontine glucose metabolism in Alzheimer disease: a reference region for functional brain image (PET) analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900230-5

7 January 2021

A diagnostic method for suspected Alzheimer's disease using H(2)15O positron emission tomography perfusion Z score

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900230-5

7 January 2021

Fluoro-deoxyglucose positron emission tomography in diffuse Lewy body disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900230-5

7 January 2021

Regional correction of positron emission tomography data for the effects of cerebral atrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900230-5

7 January 2021

Correction of PET data for partial volume effects in human cerebral cortex by MR imaging.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900230-5

7 January 2021

Regional hypometabolism in Alzheimer's disease as measured by positron emission tomography after correction for effects of partial volume averaging.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900230-5

7 January 2021

Regional glucose metabolic abnormalities are not the result of atrophy in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900230-5

7 January 2021

Forebrain ischemia studied using magnetic resonance imaging and spectroscopy

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900230-5

7 January 2021

Volumes of the entorhinal and perirhinal cortices in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900230-5

7 January 2021

Deficits in cerebral glucose metabolism demonstrated by positron emission tomography in individuals at risk of familial Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900230-5

7 January 2021

Alzheimer's disease: in vivo detection of differential vulnerability of brain regions.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900230-5

7 January 2021

Hippocampus in Alzheimer's disease: a 3-year follow-up MRI study.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900230-5

7 January 2021

Evidence for early vulnerability of the medial and inferior aspects of the temporal lobe in an 82-year-old patient with preclinical signs of dementia. Regional and laminar distribution of neurofibrillary tangles and senile plaques

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900230-5

7 January 2021

Cerebral cortex pathology in aging and Alzheimer's disease: a quantitative survey of large hospital-based geriatric and psychiatric cohorts

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900230-5

7 January 2021

MRI-based quantitative assessment of the hippocampal region in very mild to moderate Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900230-5

7 January 2021

Normal and pathological aging--findings of positron-emission-tomography.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900230-5

7 January 2021

Some morphometric aspects of the brain in senile dementia of the alzheimer type

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900230-5

7 January 2021

Quantitation of cerebral atrophy in preclinical and end-stage Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900230-5

7 January 2021

Alzheimer disease: measuring loss of cerebral gray matter with MR imaging.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900230-5

7 January 2021

10.1016/S0197-4580(01)00230-5

Identifiers

DOI

1 reference

25 November 2017

1 reference